Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

about

Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine.

P2860

Q49961017-2BB77338-D21E-4E8C-B62D-39FF2E3A9DE2

P2860

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

Item

http://www.wikidata.org/entity/Q47703811

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

@en

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

@nl

type

Item

label

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

@en

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

@nl

prefLabel

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

@en

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

@nl

P1476

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

@en

P2093

Jorge Lascano

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease

α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8

Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach

Level dominance in sound source identification.

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.

Assessment of bone vascularity in the anterior mandible using laser Doppler flowmetry.

Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis.

Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

P304

249-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-7163-3_25

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1639

http://www.w3.org/2001/XMLSchema#string

P50

Michael A. Campos

Jorge Lascano

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28752465

http://www.w3.org/2001/XMLSchema#string

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

about

P2860

P2860

Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698